Life Financial Statements From 2010 to 2025

LIFS Stock  USD 0.0002  0.00  0.00%   
Life Stem's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Life Stem's valuation are provided below:
Life Stem Genetics does not presently have any fundamental ratios for analysis.
Check Life Stem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Life Stem's main balance sheet or income statement drivers, such as , as well as many indicators such as . Life financial statements analysis is a perfect complement when working with Life Stem Valuation or Volatility modules.
  
This module can also supplement various Life Stem Technical models . Check out the analysis of Life Stem Correlation against competitors.

Life Stem Genetics Company Shares Outstanding Analysis

Life Stem's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Life Stem Shares Outstanding

    
  45.84 M  
Most of Life Stem's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Life Stem Genetics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Life Stem Genetics has 45.84 M of shares currently outstending. This is 74.61% lower than that of the Healthcare sector and 57.1% lower than that of the Biotechnology industry. The shares outstanding for all United States stocks is 91.98% higher than that of the company.

Life Stem Genetics Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Life Stem's current stock value. Our valuation model uses many indicators to compare Life Stem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Life Stem competition to find correlations between indicators driving Life Stem's intrinsic value. More Info.
Life Stem Genetics is considered the number one company in current valuation category among its peers. It is rated fourth overall in shares outstanding category among its peers creating about  302.25  of Shares Outstanding per Current Valuation. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Life Stem's earnings, one of the primary drivers of an investment's value.

About Life Stem Financial Statements

Life Stem shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Life Stem investors may analyze each financial statement separately, they are all interrelated. The changes in Life Stem's assets and liabilities, for example, are also reflected in the revenues and expenses on on Life Stem's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Life Stem Genetics Inc., a development stage company, focuses on establishing stem cell therapy based clinics worldwide. The company was founded in 2012 and is based in Beverly Hills, California. Life Stem operates under Biotechnology classification in the United States and is traded on OTC Exchange.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Life Pink Sheet Analysis

When running Life Stem's price analysis, check to measure Life Stem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Stem is operating at the current time. Most of Life Stem's value examination focuses on studying past and present price action to predict the probability of Life Stem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Stem's price. Additionally, you may evaluate how the addition of Life Stem to your portfolios can decrease your overall portfolio volatility.